Royal Bank Of Canada set a C$5.50 target price on NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Free Report) in a report issued on Monday,BayStreet.CA reports. The firm currently has a sector perform rating on the stock.
NWH.UN has been the topic of several other reports. BMO Capital Markets raised their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research report on Thursday, November 13th. Scotiabank increased their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday, November 13th. Finally, CIBC raised their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a report on Thursday, November 13th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, NorthWest Health Prop Real Est Inv Trust currently has a consensus rating of “Moderate Buy” and a consensus price target of C$6.00.
Get Our Latest Stock Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Price Performance
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) last issued its earnings results on Tuesday, November 11th. The company reported C$0.06 EPS for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The business had revenue of C$110.69 million for the quarter. On average, analysts expect that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 earnings per share for the current year.
About NorthWest Health Prop Real Est Inv Trust
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
Recommended Stories
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- Transportation Stocks Investing
- Why Gold Loves Trump as Much as Trump Loves Gold
- Growth Stocks: What They Are, What They Are Not
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.
